Last reviewed: June 26, 2026
Last updated: June 26, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Ozempic and Wegovy are both FDA-approved semaglutide medications, yet they serve distinct medical purposes and carry vastly different price tags. Understanding their similarities, differences, and efficacy can help you make an informed decision about weight loss therapy.
What Is the Difference Between Ozempic and Wegovy?
Ozempic is a weekly injectable medication originally approved by the FDA in 2017 to treat type 2 diabetes. It helps the pancreas release insulin when blood sugar rises, reducing glucose levels in patients with diabetes. Wegovy, approved in 2021, contains the identical active compound—semaglutide—but is specifically formulated and marketed for chronic weight management in adults with obesity or overweight conditions.
The core difference lies in regulatory labeling and target population, not chemical composition. Both deliver 0.5 mg to 2.4 mg of semaglutide weekly via subcutaneous injection. Patients often report similar weight loss outcomes when prescribed equivalent doses, because the medication mechanism remains unchanged. Insurance coverage, pricing, and clinical expectations differ significantly, however.
Semaglutide Efficacy for Weight Loss: Clinical Evidence
Clinical trials demonstrate that semaglutide produces meaningful weight loss across diverse populations. The landmark STEP trials, which studied Wegovy in non-diabetic adults, showed that participants receiving 2.4 mg weekly semaglutide lost an average of 15% to 18% of body weight over 68 weeks. Many participants continued losing weight into month 12, with sustained results as long as the medication was administered.
In type 2 diabetes populations taking Ozempic, weight loss averaged 4% to 6% of baseline body weight, though patients focused on glucose control rather than weight as the primary endpoint. The higher doses used in obesity trials (up to 2.4 mg weekly) consistently outperformed lower doses. Real-world adherence and personalized dosing protocols can influence individual outcomes, making genetic and metabolic profiling increasingly relevant for optimizing therapy.
Cost Comparison: Why Medication Access Matters
Ozempic and Wegovy carry sticker prices of $900 to $1,400+ per month, depending on your pharmacy and insurance status. Uninsured patients often pay the full retail price, while insured patients may face high copays or prior authorization delays. Many patients abandon therapy due to cost, despite strong clinical motivation to continue.
PlexusDx compounded semaglutide injections start at $149 per month through licensed 503A compounding pharmacies, delivering the same active pharmaceutical ingredient at a fraction of the brand-name cost. No insurance is required, and the medication remains HSA/FSA eligible. This pricing model ensures consistent monthly cost regardless of dose escalation—your dose may need to go up, but your price won't.
Personalized Semaglutide Therapy: The Role of Genetic Testing
Not all patients respond equally to semaglutide. Genetic variations in the GLP-1 receptor (GLP1R rs6923761), GIPR pathway (rs1800437), and appetite-regulation genes such as FTO (rs9939609) and MC4R (rs17782313) influence medication efficacy and side effect tolerance. Two patients on identical doses may experience vastly different weight loss trajectories based on these peptide-pathway variants.
PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) maps 14 metabolic pathways, 49 peptides, and 150+ genetic insights to predict your individual semaglutide response. This allows your clinician to optimize your protocol—whether through dose adjustment, combination therapy with tirzepatide, or microdose protocols—before investing months in a suboptimal treatment plan. Personalization increases both efficacy and patient satisfaction with therapy.
Ozempic vs. Wegovy vs. Compounded Semaglutide: Which Should You Choose?
Ozempic remains the standard diabetes treatment when glucose control is the primary goal. If your insurance covers Ozempic and you have moderate copays, that pathway may be convenient. Wegovy is the FDA-approved weight loss label, preferred by patients and insurers focused exclusively on obesity treatment, but coverage remains limited and copays are often prohibitive.
Compounded semaglutide from PlexusDx offers medical-equivalent efficacy without the brand-name markup. Because it's sourced from licensed 503A compounding pharmacies and dispensed across all 50 states, access is immediate and transparent. Patients can start therapy within days, combine semaglutide with other peptides if needed, and access genetic testing to optimize their personal response profile. The choice ultimately depends on your insurance status, budget, and whether personalization matters for your specific metabolic profile.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is Ozempic or Wegovy more effective for weight loss?
Both contain identical semaglutide and produce similar weight loss when dosed equivalently. Wegovy is specifically approved for weight management and typically uses higher doses (up to 2.4 mg weekly), while Ozempic is labeled for diabetes. Efficacy depends more on your individual genetics and adherence than on which brand you choose.
Why is Wegovy so much more expensive than Ozempic?
Wegovy carries a premium price because it's FDA-approved specifically for weight loss, allowing manufacturers to charge obesity-market prices. Ozempic costs less partly due to established diabetes-market pricing and higher prescription volume. Neither reflects the actual production cost of semaglutide, which is why compounded versions cost significantly less.
Is compounded semaglutide as safe as Ozempic or Wegovy?
Yes. PlexusDx sources compounded semaglutide from licensed 503A compounding pharmacies operating under strict FDA regulations. The active compound is pharmaceutical-grade and identical to brand medications. Safety depends on proper dosing, medical supervision, and patient screening—not whether the medication is brand-name or compounded.
How much does PlexusDx semaglutide cost compared to brand names?
PlexusDx compounded semaglutide injections start at $149 per month, compared to $900–$1,400+ for Ozempic or Wegovy. Your price remains flat regardless of dose level—no surprise increases as your clinician optimizes your therapy. HSA/FSA benefits apply, and no insurance is required.
Can genetic testing help predict whether semaglutide will work for me?
Yes. PlexusDx Precision Peptide Genetic Test identifies key variants in GLP1R, GIPR, FTO, and MC4R genes that influence semaglutide response and side effect risk. Testing ($99 after your first month) allows your clinician to personalize your dose, switch to tirzepatide, or adjust your protocol before wasting time on a suboptimal approach.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Why Is Ozempic Not Making Me Lose Weight?
How to Wean Off Ozempic for Weight Loss: A Comprehensive Guide